Ticker > Company >

Choksi Lab share price

Choksi Laboratories Ltd.

BSE: 526546 SECTOR: Hospital & Healthcare Services  13k   11   1

65.39
+4.78 (7.89%)
BSE: Today, 12:35 PM

Price Summary

Today's High

₹ 70.6

Today's Low

₹ 63.8

52 Week High

₹ 94

52 Week Low

₹ 38.32

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

45.55 Cr.

Enterprise Value

74.16 Cr.

No. of Shares

0.7 Cr.

P/E

36.64

P/B

1.98

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  33.04

CASH

0.66 Cr.

DEBT

29.27 Cr.

Promoter Holding

31.48 %

EPS (TTM)

₹  1.78

Sales Growth

6.55%

ROE

5.12 %

ROCE

9.18%

Profit Growth

-65.43 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year6.55%
3 Year12.62%
5 Year1.69%

Profit Growth

1 Year-65.43%
3 Year34.36%
5 Year-7.06%

ROE%

1 Year5.12%
3 Year7.58%
5 Year-1.71%

ROCE %

1 Year9.18%
3 Year9.94%
5 Year4.32%

Debt/Equity

1.318

Price to Cash Flow

3.94

Interest Cover Ratio

1.5433

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 31.48 0.00
Jun 2024 31.48 0.00
Mar 2024 31.48 0.00
Dec 2023 31.48 0.00
Sep 2023 31.48 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The Company has been maintaining an effective average operating margins of 22.7194246200231% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -301.0919 days.

 Limitations

  • The company has shown a poor revenue growth of 12.6225642614015% for the Past 3 years.
  • Company has a poor ROE of 7.5807098045376% over the past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 7.95 8.8 11.18 10.74 9.26
Total Expenditure 5.84 6.55 7.64 7.9 6.9
Operating Profit 2.11 2.24 3.55 2.84 2.36
Other Income 0.05 0 0 0 0.01
Interest 0.74 0.67 0.77 0.72 0.66
Depreciation 1.41 1.43 1.49 1.5 1.61
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.01 0.15 1.29 0.62 0.1
Tax 0 0.08 0.6 0.19 0.02
Profit After Tax 0.01 0.06 0.68 0.42 0.08
Adjusted EPS (Rs) 0.01 0.09 0.98 0.6 0.11

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 28.16 25.69 30.04 34.44 36.7
Total Expenditure 25.32 21.56 21.14 24.18 26.42
Operating Profit 2.84 4.13 8.91 10.26 10.27
Other Income 0.33 0.49 0.12 0.22 0.16
Interest 1.89 2.82 3.23 3.52 3.06
Depreciation 4.56 4.6 5.43 5.5 5.71
Exceptional Items -2.43 0 0 2.26 0
Profit Before Tax -5.71 -2.81 0.37 3.72 1.66
Tax -1.83 -0.2 0.16 0.51 0.55
Net Profit -3.88 -2.61 0.21 3.21 1.11
Adjusted EPS (Rs.) -5.58 -3.74 0.3 4.61 1.59

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 6.97 6.97 6.97 6.97 6.97
Total Reserves 13.26 10.78 10.94 14.14 15.25
Borrowings 27.36 28.82 27.54 23.61 18
Other N/C liabilities 1.57 2.06 2.06 2.25 2.51
Current liabilities 14.48 16.22 15.52 12.51 18.85
Total Liabilities 63.63 64.85 63.03 59.49 61.56
Assets
Net Block 33.08 50.32 46.56 44.83 43.43
Capital WIP 13.06 0.5 1.56 0.02 2.68
Intangible WIP 0 0 0.11 0.29 0.32
Investments 0 0 0 0 0
Loans & Advances 0.57 0.55 0.33 0.22 0.28
Other N/C Assets 0.37 0.44 0.46 0.18 0.29
Current Assets 16.54 13.03 14.01 13.95 14.57
Total Assets 63.63 64.85 63.03 59.49 61.56
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -5.71 -2.81 0.37 3.72 1.66
Adjustment 7.08 6.93 8.72 6.9 8.78
Changes in Assets & Liabilities 2.57 -1.34 -2.39 -3.11 1.6
Tax Paid -1.07 3.11 1.17 0.74 -0.49
Operating Cash Flow 2.87 5.9 7.88 8.25 11.55
Investing Cash Flow -13.76 -7.65 -2.71 -0.71 -6.65
Financing Cash Flow 11.09 1.63 -5.07 -7.61 -4.58
Net Cash Flow 0.2 -0.12 0.1 -0.07 0.32

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 31.48 31.48 31.48 31.48 31.48
choksi holding company pr... 4.31 4.31 4.31 4.31 4.31
himika choksi 0.01 0.01 0.01 0.01 0.01
khyati choksi 4.33 4.33 4.33 4.33 4.33
stela choksi 3.16 3.16 3.16 3.16 3.16
sunil choksi 7.51 7.51 7.51 7.51 7.51
sunil kumar choksi 5.74 5.74 5.74 5.74 5.74
vyangesh choksi 6.42 6.42 6.42 6.42 6.42
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 68.52 68.52 68.52 68.52 68.52
dheeraj kumar lohia 4.09 3.09 2.55 2.37 2.37
gaurav anand 2.87 2.87 2.87 2.87 2.87
kinjal rajnikant maniar - 1.09 1.09 1.09 1.09
mahendra girdharilal - - - 1.32 1.32
quest laboratories pvt.lt... 2.04 2.04 2.04 2.04 2.04
sachin seth 4.76 4.76 4.76 4.76 3.96
shantanu trivedi 2.15 2.15 2.15 2.15 2.15
timsy kapoor 2.15 2.15 2.15 2.15 2.15
zaki abbas nasser - - - 1.79 1.15
llp - 0.95 0.84 0.39 -
bobby mathews 1.44 1.44 - - -
alka jain 1.08 - - - -
mehul suresh parikh 1.03 - - - -

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Choksi Laboratories informs about issue of share certificates 22 Oct, 1:48 PM Choksi Laboratories informs about compliance certificate 14 Oct, 5:32 PM Choksi Laboratories informs about newspaper clipping 27 Aug, 2:47 PM Choksi Lab - Quaterly Results 13 Aug, 2:54 PM Choksi Lab - Quaterly Results 13 Aug, 2:54 PM Choksi Laboratories informs about compliance certificate 18 Apr, 4:47 PM Choksi Laboratories informs about outcome of board meeting 3 Feb, 4:04 PM Choksi Lab - Quaterly Results 3 Feb, 2:23 PM Choksi Lab - Quaterly Results 3 Feb, 2:23 PM Choksi Lab - Quaterly Results 3 Feb, 2:23 PM Choksi Laboratories submits unaudited financial results 10 Nov, 4:17 PM Choksi Lab - Quaterly Results 12 Aug, 1:19 PM Choksi Laboratories informs about outcome of board meeting 5 Jul, 5:07 PM Choksi Laboratories informs about compliances-certificate 11 Apr, 5:42 PM Choksi Lab - Quaterly Results 13 Feb, 4:04 PM Choksi Lab - Quaterly Results 13 Feb, 4:04 PM Choksi Laboratories informs about outcome of board meeting 12 Dec, 12:29 PM Choksi Laboratories informs about board meeting 7 Dec, 4:43 PM Choksi Laboratories informs about updates 23 Nov, 4:47 PM Choksi Laboratories informs about AGM 24 Sep, 4:15 PM Choksi Laboratories informs about appointment of director 18 Aug, 12:49 PM Choksi Laboratories informs about resignation of independent director 15 Jul, 5:00 PM Choksi Laboratories informs about related party transactions 4 Jun, 11:29 AM Choksi Laboratories informs about outcome of board meeting 13 Aug, 5:16 PM Choksi Laboratories informs about confirmation certificate 18 Jan, 3:22 PM Choksi Laboratories informs about closure of trading window 1 Jan, 1:53 PM Choksi Lab - Quaterly Results 29 Aug, 4:35 PM

Choksi Lab Stock Price Analysis and Quick Research Report. Is Choksi Lab an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Choksi Lab and its performance over the period of time. Choksi Lab stock price today is Rs 65.39.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Choksi Lab cash from the operating activity was Rs 11.5515 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Choksi Lab has a Debt to Equity ratio of 1.318 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Choksi Lab , the EPS growth was -65.4277 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Choksi Lab has OPM of 27.9985611157893 % which is a good sign for profitability.
     
  • ROE: Choksi Lab have a poor ROE of 5.1239 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Choksi Lab is Rs 65.39. One can use valuation calculators of ticker to know if Choksi Lab share price is undervalued or overvalued.
Last Updated on:
Brief about Choksi Lab
X